DUX4 Is a Common Driver of Immune Evasion and Immunotherapy Failure in Metastatic Cancers

Researchers reported that DUX4 expression is a common feature of metastatic tumors. DUX4 expression was significantly associated with immune cell exclusion and decreased objective response to PD-L1 blockade in a large cohort of urothelial carcinoma patients.